AngioDynamics Inc
NASDAQ:ANGO

Watchlist Manager
AngioDynamics Inc Logo
AngioDynamics Inc
NASDAQ:ANGO
Watchlist
Price: 6.83 USD -1.73% Market Closed
Market Cap: 277.5m USD
Have any thoughts about
AngioDynamics Inc?
Write Note

AngioDynamics Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AngioDynamics Inc
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
AngioDynamics Inc
NASDAQ:ANGO
Cost of Revenue
-$141.4m
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
2%
Becton Dickinson and Co
NYSE:BDX
Cost of Revenue
-$11B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-10%
Boston Scientific Corp
NYSE:BSX
Cost of Revenue
-$4.9B
CAGR 3-Years
-9%
CAGR 5-Years
-10%
CAGR 10-Years
-8%
Stryker Corp
NYSE:SYK
Cost of Revenue
-$7.9B
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Cost of Revenue
-$18.3B
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cost of Revenue
-$2.6B
CAGR 3-Years
-15%
CAGR 5-Years
-15%
CAGR 10-Years
-14%
No Stocks Found

AngioDynamics Inc
Glance View

Market Cap
280.1m USD
Industry
Health Care

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 800 full-time employees. The company went IPO on 2004-05-27. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.

ANGO Intrinsic Value
6.58 USD
Overvaluation 4%
Intrinsic Value
Price

See Also

What is AngioDynamics Inc's Cost of Revenue?
Cost of Revenue
-141.4m USD

Based on the financial report for Aug 31, 2024, AngioDynamics Inc's Cost of Revenue amounts to -141.4m USD.

What is AngioDynamics Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
2%

Over the last year, the Cost of Revenue growth was 14%. The average annual Cost of Revenue growth rates for AngioDynamics Inc have been -1% over the past three years , -4% over the past five years , and 2% over the past ten years .

Back to Top